AI brief of an SEC Form 8-K · Quantumsphere Acquisition Corp (QUMS)

Quantumsphere Acquisition signs merger agreement with Fortune Favor Technology

Neutral Impact 5 of 5 m&a Written later

Quantumsphere Acquisition Corp (QUMS), a special purpose acquisition company, entered into a merger agreement on October 9, 2026 with Fortune Favor Technology Inc., a provider of technology consulting and solutions for medical cold-chain transportation. The deal implies a pre-money equity value of about $600 million for Fortune Favor, and completion depends on shareholder approvals, an SEC registration statement and Nasdaq listing approval.

Key points

  • Agreement signed October 9, 2026; each Fortune Favor share is valued at $10.00 in Purchaser ordinary shares, based on a pre-money equity valuation of about $600 million
  • Each Quantumsphere ordinary share converts into one Purchaser ordinary share; each right converts into one-seventh of a Purchaser ordinary share
  • Sponsor Whiteowl Holdings LLC and certain Fortune Favor shareholders agreed to support support agreements; lock-up lasts 180 days after closing or until shares close at or above $12.50 for 20 of 30 trading days
  • Either party may terminate if the other causes a delay exceeding six months; a $500,000 break-up fee applies in certain cases

The filing

CompanyQuantumsphere Acquisition Corp (QUMS)
Form8-K, current report
Filed with the SECOct 13, 2026, 4:05 PM ET
Accession number0001829126-26-011072

Items reported: 1.01 Material Definitive Agreement7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.